222 related articles for article (PubMed ID: 27257717)
1. Metabolism and toxicological analysis of synthetic cannabinoids in biological fluids and tissues.
Presley BC; Gurney SM; Scott KS; Kacinko SL; Logan BK
Forensic Sci Rev; 2016 Jul; 28(2):103-69. PubMed ID: 27257717
[TBL] [Abstract][Full Text] [Related]
2. Approaches, Challenges, and Advances in Metabolism of New Synthetic Cannabinoids and Identification of Optimal Urinary Marker Metabolites.
Diao X; Huestis MA
Clin Pharmacol Ther; 2017 Feb; 101(2):239-253. PubMed ID: 27727455
[TBL] [Abstract][Full Text] [Related]
3. Detection of synthetic cannabinoids in oral fluid using ELISA and LC-MS-MS.
Rodrigues WC; Catbagan P; Rana S; Wang G; Moore C
J Anal Toxicol; 2013 Oct; 37(8):526-33. PubMed ID: 23946452
[TBL] [Abstract][Full Text] [Related]
4. Determination and identification of synthetic cannabinoids and their metabolites in different matrices by modern analytical techniques - a review.
Znaleziona J; Ginterová P; Petr J; Ondra P; Válka I; Ševčík J; Chrastina J; Maier V
Anal Chim Acta; 2015 May; 874():11-25. PubMed ID: 25910441
[TBL] [Abstract][Full Text] [Related]
5. Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey.
Gurdal F; Asirdizer M; Aker RG; Korkut S; Gocer Y; Kucukibrahimoglu EE; Ince CH
J Forensic Leg Med; 2013 Aug; 20(6):667-72. PubMed ID: 23910858
[TBL] [Abstract][Full Text] [Related]
6. Oral Fluid vs. Urine Analysis to Monitor Synthetic Cannabinoids and Classic Drugs Recent Exposure.
Blandino V; Wetzel J; Kim J; Haxhi P; Curtis R; Concheiro M
Curr Pharm Biotechnol; 2017; 18(10):796-805. PubMed ID: 29173162
[TBL] [Abstract][Full Text] [Related]
7. Screening of synthetic cannabinoids in preserved oral fluid by UPLC-MS/MS.
Oiestad EL; Johansen U; Christophersen AS; Karinen R
Bioanalysis; 2013 Sep; 5(18):2257-68. PubMed ID: 24053241
[TBL] [Abstract][Full Text] [Related]
8. Qualitative analysis of seized synthetic cannabinoids and synthetic cathinones by gas chromatography triple quadrupole tandem mass spectrometry.
Gwak S; Arroyo-Mora LE; Almirall JR
Drug Test Anal; 2015 Feb; 7(2):121-30. PubMed ID: 24827678
[TBL] [Abstract][Full Text] [Related]
9. Acute kidney injury associated with smoking synthetic cannabinoid.
Buser GL; Gerona RR; Horowitz BZ; Vian KP; Troxell ML; Hendrickson RG; Houghton DC; Rozansky D; Su SW; Leman RF
Clin Toxicol (Phila); 2014 Aug; 52(7):664-73. PubMed ID: 25089722
[TBL] [Abstract][Full Text] [Related]
10. Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry.
Shanks KG; Dahn T; Behonick G; Terrell A
J Anal Toxicol; 2012 Jul; 36(6):360-71. PubMed ID: 22586208
[TBL] [Abstract][Full Text] [Related]
11. Rapid identification of synthetic cannabinoids in herbal samples via direct analysis in real time mass spectrometry.
Musah RA; Domin MA; Walling MA; Shepard JR
Rapid Commun Mass Spectrom; 2012 May; 26(9):1109-14. PubMed ID: 22467461
[TBL] [Abstract][Full Text] [Related]
12. Emerging Synthetic Cannabinoids: Development and Validation of a Novel Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry Assay for Real-Time Detection.
Krotulski AJ; Mohr ALA; Logan BK
J Anal Toxicol; 2020 Apr; 44(3):207-217. PubMed ID: 31909808
[TBL] [Abstract][Full Text] [Related]
13. High-resolution mass spectrometric determination of the synthetic cannabinoids MAM-2201, AM-2201, AM-2232, and their metabolites in postmortem plasma and urine by LC/Q-TOFMS.
Zaitsu K; Nakayama H; Yamanaka M; Hisatsune K; Taki K; Asano T; Kamata T; Katagai M; Hayashi Y; Kusano M; Tsuchihashi H; Ishii A
Int J Legal Med; 2015 Nov; 129(6):1233-45. PubMed ID: 26349566
[TBL] [Abstract][Full Text] [Related]
14. Synthetic cannabinoids: analysis and metabolites.
Elsohly MA; Gul W; Wanas AS; Radwan MM
Life Sci; 2014 Feb; 97(1):78-90. PubMed ID: 24412391
[TBL] [Abstract][Full Text] [Related]
15. Direct analysis in real time mass spectrometry with collision-induced dissociation for structural analysis of synthetic cannabinoids.
Musah RA; Domin MA; Cody RB; Lesiak AD; Dane AJ; Shepard JR
Rapid Commun Mass Spectrom; 2012 Oct; 26(19):2335-42. PubMed ID: 22956326
[TBL] [Abstract][Full Text] [Related]
16. The Evolving Landscape of Designer Drugs.
Kacinko SL; Papsun DM
Methods Mol Biol; 2019; 1872():129-135. PubMed ID: 30350286
[TBL] [Abstract][Full Text] [Related]
17. Biosampling strategies for emerging drugs of abuse: towards the future of toxicological and forensic analysis.
Mercolini L; Protti M
J Pharm Biomed Anal; 2016 Oct; 130():202-219. PubMed ID: 27424495
[TBL] [Abstract][Full Text] [Related]
18. Detection and quantification of new designer drugs in human blood: Part 1 - Synthetic cannabinoids.
Ammann J; McLaren JM; Gerostamoulos D; Beyer J
J Anal Toxicol; 2012 Jul; 36(6):372-80. PubMed ID: 22593567
[TBL] [Abstract][Full Text] [Related]
19. Oral fluid drug analysis in the age of new psychoactive substances.
Øiestad EL; Øiestad ÅM; Gjelstad A; Karinen R
Bioanalysis; 2016 Apr; 8(7):691-710. PubMed ID: 26964619
[TBL] [Abstract][Full Text] [Related]
20. Use of SPME-HS-GC-MS for the analysis of herbal products containing synthetic cannabinoids.
Cox AO; Daw RC; Mason MD; Grabenauer M; Pande PG; Davis KH; Wiley JL; Stout PR; Thomas BF; Huffman JW
J Anal Toxicol; 2012 Jun; 36(5):293-302. PubMed ID: 22582264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
